4//SEC Filing
Jacobs John C 4
Accession 0001415889-22-008696
CIK 0001802665other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:04 PM ET
Size
11.0 KB
Accession
0001415889-22-008696
Insider Transaction Report
Form 4
Jacobs John C
DirectorPresident, CEO
Transactions
- Exercise/Conversion
Common Stock
2022-08-15$8.22/sh+40,000$328,800→ 40,000 total - Sale
Common Stock
2022-08-15$51.76/sh−909$47,053→ 0 total - Sale
Common Stock
2022-08-15$51.05/sh−39,091$1,995,760→ 909 total - Exercise/Conversion
Stock Option
2022-08-15−40,000→ 114,751 totalExercise: $8.22Exp: 2027-10-02→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.56 to $51.54. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.56 to $52.05. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The stock option vests in five equal annual installments beginning on October 1, 2018.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
Related Parties
1- filerCIK 0001820836
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:04 PM ET
- Size
- 11.0 KB